Many people are unaware that Pharmaceutical Companies invest, on average, 500 million pounds to develop a new medicine or drug. Many of these drugs never even get near to the final stages. It takes up to 20 years for a new drug to be licensed for public use from its conception. So, what has to happen before a new drug can be sold at a pharmacist or be prescribed by a doctor?
The MHRA have strict laws to control every stage. Everything about a study, including the advertisements, has to be approved by an ethical review committee. They are made up of scientists, doctors and lay people who have the power to halt a study and demand changes. After years of laboratory testing, it is mandatory for these compounds to be given firstly to live animals. The drug companies have no option as the law demands it. Sometimes side effects are found in animals and the developing study has to be abandoned.
Whilst the public may know more about the animal testing phase, they are not so aware of the human healthy volunteer trials known as studies. Thousands of volunteers participate in studies of new and reformulated medicines every year. This article shows why volunteers can receive hundreds or thousands of pounds in reimbursement for their time and effort.
Healthy volunteers are recruited from the public. Advertising targets certain people groups. There are many exclusion criteria to overcome for a candidate to be accepted on to the database of volunteers. Their weight, height, blood pressure and medical history are assessed, together with a detailed report from their own doctor. The general practitioner can deselect their patient without giving any reason. The pharmaceutical company pays thousands of pounds every year to the NHS for this medical service. This ensures that volunteers do not withhold important medical information and put their lives at risk to obtain a financial reward.
When a suitable study is available, hundreds of volunteers are mailed with brief details and dates. They are not informed how much money is involved. They then need to pass a medical, including height, weight, blood pressure, ECG, blood and urine tests. They also need to pass a medical examination by the physician in charge of the study. The slightest anomaly can exclude a volunteer. They are withdrawn and given a minimal payment for their attendance. Usually, only 15% of the study candidates reach this far. Twenty or less volunteers are now left to participate in the study. There are normally three separate study admissions over three months with repeat groups taking different doses of the drug. The volunteers will all have undergone certain restrictions for various periods of time. These include food, drink, alcohol and exercise. Blood tests will reveal any deviation in following the restrictions. Even an innocent mouthful of broccoli will be detected in the blood tests if it has been a restricted food.
After a week, the volunteers return for the study. They are admitted onto a ward for three or more days. They undergo another full medical. Any abnormalities bring further losses to the volunteers who are now called subjects. They remain on bed rest for the first six hours as the study drug or placebo is administered. Several doctors, a pharmacist and trained nurses are all present with the subjects for the first day and throughout the study. Recordings are made every thirty minutes and written in the patient records or CRF. Print outs are kept for the blood pressure and ECG. A cannula or tube is kept in the subject’s vein for twenty-four hours. This facilitates repeat blood samples and allows access for an intravenous drug to be injected in an emergency. Any adverse effects are investigated and documented immediately. If appropriate, the subject is taken off the study and given full payment. Volunteers may withdraw from a study at any time.
After completion of a study, the volunteers return for a post study medical. All the tests are repeated. Each volunteer has to be completely healthy to be released and paid for his or her participation. Some studies can require as many as twenty repeat visits to measure the levels of the test drug in the bloodstream.
Without these drug studies, simple aspirins, antibiotics, vaccinations, anaesthetics or even oxygen would not be available for sale or prescription. It’s thanks to all the healthy men and women volunteers that our lives are made much easier.
Pharmaceutical companies invest an average of 500 million pounds and up to 20 years to develop a new drug, with many never reaching the final stages due to strict regulatory requirements overseen by the MHRA. The drug development process involves extensive laboratory testing followed by mandatory animal trials, where side effects can lead to abandoned studies. A lesser-known but crucial phase involves human healthy volunteer trials, where thousands of people participate annually in studies of new medicines, receiving substantial financial compensation for their time and effort.
The volunteer recruitment process is highly selective, with strict exclusion criteria including medical history, physical measurements, and GP approval, resulting in only about 15% of initial candidates making it through screening. During the actual studies, volunteers undergo intensive monitoring over several days in hospital wards, with constant medical supervision, frequent blood tests, and detailed documentation of any effects or reactions. The entire process, from initial screening through post-study medical checks, ensures volunteer safety while generating the critical data needed for drug approval.
Without these carefully controlled human trials involving dedicated volunteers, common medications like aspirin, antibiotics, and vaccines would not be available to the public.
Pharmaceutical companies invest an average of 500 million pounds and up to 20 years to develop a new drug, with many never reaching the market due to strict regulatory oversight by the MHRA. After extensive laboratory testing, drugs must undergo mandatory animal trials where side effects can force companies to abandon development entirely. A crucial but lesser-known phase involves human healthy volunteer trials, where thousands of people participate annually in studies of new medicines, receiving substantial financial compensation for their participation.
The volunteer selection process is extremely rigorous, with strict medical and physical criteria that result in only about 15% of initial candidates making it through screening. During actual studies, volunteers spend several days in hospital wards under intensive medical supervision, with constant monitoring, frequent blood tests, and detailed documentation of any reactions or side effects. Post-study medical checks ensure volunteers are completely healthy before being released and paid for their participation.
Without these carefully controlled human trials involving dedicated volunteers, common medications like aspirin, antibiotics, vaccines, and anesthetics would not be available to the public today.
Pharmaceutical companies invest an average of 500 million pounds and up to 20 years to develop a new drug, with many never reaching the market due to strict regulatory oversight by the MHRA and mandatory testing requirements. After extensive laboratory work, drugs must undergo animal trials where discovered side effects can force companies to abandon development entirely. A crucial but lesser-known phase involves human healthy volunteer trials, where thousands of people participate annually in studies of new medicines, receiving substantial financial compensation for their time and involvement.
The volunteer selection process is extremely rigorous, with strict medical and physical criteria including weight, blood pressure, medical history, and GP approval, resulting in only about 15% of initial candidates making it through the comprehensive screening process. During the actual studies, volunteers spend several days in hospital wards under intensive medical supervision, with constant monitoring every 30 minutes, frequent blood tests through inserted cannulas, and detailed documentation of any reactions or side effects. The entire process concludes with post-study medical examinations to ensure volunteers are completely healthy before receiving their final payment, with some studies requiring up to twenty follow-up visits to monitor drug levels in the bloodstream.
Pharmaceutical companies invest an average of 500 million pounds and up to 20 years to develop a new drug, with many never reaching the market due to strict regulatory oversight by the MHRA and mandatory testing requirements. After extensive laboratory work, drugs must undergo animal trials where discovered side effects can force companies to abandon development entirely. A crucial but lesser-known phase involves human healthy volunteer trials, where thousands of people participate annually in studies of new medicines, receiving substantial financial compensation for their time and involvement.
The volunteer selection process is extremely rigorous, with strict medical and physical criteria including weight, blood pressure, medical history, and GP approval, resulting in only about 15% of initial candidates making it through the comprehensive screening process. During the actual studies, volunteers spend several days in hospital wards under intensive medical supervision, with constant monitoring every 30 minutes, frequent blood tests through inserted cannulas, and detailed documentation of any reactions or side effects. The entire process concludes with post-study medical examinations to ensure volunteers are completely healthy before receiving their final payment, with some studies requiring up to twenty follow-up visits to monitor drug levels in the bloodstream.
Pharmaceutical companies invest an average of 500 million pounds and up to 20 years to develop a new drug, with many never reaching the market due to strict regulatory oversight by the MHRA and mandatory testing requirements. After extensive laboratory work, drugs must undergo animal trials where discovered side effects can force companies to abandon development entirely. A crucial but lesser-known phase involves human healthy volunteer trials, where thousands of people participate annually in studies of new medicines, receiving substantial financial compensation for their time and involvement.
The volunteer selection process is extremely rigorous, with strict medical and physical criteria including weight, blood pressure, medical history, and GP approval, resulting in only about 15% of initial candidates making it through the comprehensive screening process. During the actual studies, volunteers spend several days in hospital wards under intensive medical supervision, with constant monitoring every 30 minutes, frequent blood tests through inserted cannulas, and detailed documentation of any reactions or side effects. The entire process concludes with post-study medical examinations to ensure volunteers are completely healthy before receiving their final payment, with some studies requiring up to twenty follow-up visits to monitor drug levels in the bloodstream.
Pharmaceutical companies invest an average of 500 million pounds and up to 20 years to develop a new drug, with many never reaching the market due to strict regulatory oversight by the MHRA and mandatory testing requirements. After extensive laboratory work, drugs must undergo animal trials where discovered side effects can force companies to abandon development entirely. A crucial but lesser-known phase involves human healthy volunteer trials, where thousands of people participate annually in studies of new medicines, receiving substantial financial compensation for their time and involvement. The volunteer selection process is extremely rigorous, with strict medical and physical criteria including weight, blood pressure, medical history, and GP approval, resulting in only about 15% of initial candidates making it through the comprehensive screening process. During the actual studies, volunteers spend several days in hospital wards under intensive medical supervision, with constant monitoring every 30 minutes, frequent blood tests through inserted cannulas, and detailed documentation of any reactions or side effects. Without these carefully controlled human trials involving dedicated volunteers, common medications like aspirin, antibiotics, vaccines, and anesthetics would not be available to the public today.
Pharmaceutical companies invest an average of 500 million pounds and up to 20 years to develop a new drug, with many never reaching the market due to strict regulatory oversight by the MHRA and mandatory testing requirements. After extensive laboratory work, drugs must undergo animal trials where discovered side effects can force companies to abandon development entirely. A crucial but lesser-known phase involves human healthy volunteer trials, where thousands of people participate annually in studies of new medicines, receiving substantial financial compensation for their time and involvement. The volunteer selection process is extremely rigorous, with strict medical and physical criteria including weight, blood pressure, medical history, and GP approval, resulting in only about 15% of initial candidates making it through the comprehensive screening process. During the actual studies, volunteers spend several days in hospital wards under intensive medical supervision, with constant monitoring every 30 minutes, frequent blood tests through inserted cannulas, and detailed documentation of any reactions or side effects. Without these carefully controlled human trials involving dedicated volunteers, common medications like aspirin, antibiotics, vaccines, and anesthetics would not be available to the public today.
Pharmaceutical companies invest an average of 500 million pounds and up to 20 years to develop a new drug, with many never reaching the market due to strict regulatory oversight by the MHRA and mandatory testing requirements. After extensive laboratory work, drugs must undergo animal trials where discovered side effects can force companies to abandon development entirely. A crucial but lesser-known phase involves human healthy volunteer trials, where thousands of people participate annually in studies of new medicines, receiving substantial financial compensation for their time and involvement. The volunteer selection process is extremely rigorous, with strict medical and physical criteria including weight, blood pressure, medical history, and GP approval, resulting in only about 15% of initial candidates making it through the comprehensive screening process. During the actual studies, volunteers spend several days in hospital wards under intensive medical supervision, with constant monitoring every 30 minutes, frequent blood tests through inserted cannulas, and detailed documentation of any reactions or side effects. Without these carefully controlled human trials involving dedicated volunteers, common medications like aspirin, antibiotics, vaccines, and anesthetics would not be available to the public today.
Pharmaceutical companies invest an average of 500 million pounds and up to 20 years to develop a new drug, with many never reaching the market due to strict regulatory oversight by the MHRA and mandatory testing requirements. After extensive laboratory work, drugs must undergo animal trials where discovered side effects can force companies to abandon development entirely. A crucial but lesser-known phase involves human healthy volunteer trials, where thousands of people participate annually in studies of new medicines, receiving substantial financial compensation for their time and involvement. The volunteer selection process is extremely rigorous, with strict medical and physical criteria including weight, blood pressure, medical history, and GP approval, resulting in only about 15% of initial candidates making it through the comprehensive screening process. During the actual studies, volunteers spend several days in hospital wards under intensive medical supervision, with constant monitoring every 30 minutes, frequent blood tests through inserted cannulas, and detailed documentation of any reactions or side effects. Without these carefully controlled human trials involving dedicated volunteers, common medications like aspirin, antibiotics, vaccines, and anesthetics would not be available to the public today.
As someone who works in clinical research, I can confirm these timelines are accurate and often even longer. The rigorous testing phases are absolutely necessary for patient safety, even though it’s frustrating when promising treatments take so long to reach those who need them.